Gracilin-Derivatives as Lead Compounds for Anti-inflammatory Effects

Area of Science:

• Marine natural products chemistry
• Immunology and inflammation research

Background:

• Gracilins, diterpenes from Spongionella gracilis, exhibit antioxidant, immunosuppressive, and neuroprotective properties.
• Their biological activity is linked to cyclophilin affinity, suggesting therapeutic potential.

Purpose of the Study:

• To investigate the anti-inflammatory and immunosuppressive effects of gracilin L and two synthetic analogues (compounds 1 and 2).
• To evaluate their impact on cellular inflammatory pathways using a murine BV2 microglia model.
• To assess neuroprotective effects in a neuron-microglia co-culture system.

Main Methods:

• Murine BV2 microglia cells were pre-treated with gracilins and analogues, then stimulated with lipopolysaccharide.
• Assessed reactive oxygen species, mitochondrial membrane potential, nitric oxide, IL-6, and TNF-α release.
• Measured expression of Nrf2, NF-κB, iNOS, and cyclophilin A; utilized neuron-microglia co-cultures for neuroprotection assessment.

Main Results:

• Gracilins and analogues significantly reduced inflammatory mediators (NO, IL-6, TNF-α) and inflammatory protein expression (iNOS, NF-κB).
• Compounds activated the anti-oxidative Nrf2 pathway under inflammatory conditions.
• Demonstrated a decrease in reactive oxygen species and preserved mitochondrial membrane potential.

Conclusions:

• Natural and synthetic gracilins effectively modulate inflammatory and immunosuppressive pathways.
• These compounds exhibit significant anti-inflammatory and antioxidant properties in microglia.
• Gracilins represent promising candidates for the development of novel anti-inflammatory therapeutics.